Consortium Tracking Tumor Mutations to Guide Lung Cancer Treatment, Clinical Trial Inclusion
June 06, 2011
Consortium Tracking Tumor Mutations to Guide Lung Cancer Treatment, Clinical Trial Inclusion
By testing 1,000 individuals with lung cancer for driver mutations in 10 genes, members of the Lung Cancer Mutation Consortium are finding mutations to help physicians offer more targeted treatment and clinical trial options for those with the disease.
Full-text access for registered users only.
Existing users login here.
New to GenomeWeb? Register here quickly for free access.
New to GenomeWeb? Register here quickly for free access.
Related Stories
- Mass General Study Suggests Benefit from Broad NSCLC Genotyping in Routine Clinical Practice
December 7, 2011 / Pharmacogenomics Reporter - Researchers Test Multiplex Genotyping of Lung Cancer Samples in Clinical Setting
November 9, 2011 / GenomeWeb Daily News - Study Suggests Genetic Susceptibility to T2D May Have Shifted with Human Migration
May 24, 2013 / GenomeWeb Daily News - Study of Normally Silent Somatic Tissue Genes Leads to Potential Prognostic Signature in Lung Cancer
May 23, 2013 / GenomeWeb Daily News - Researchers Report on Mutational Patterns in Adenoid Cystic Carcinoma
May 20, 2013 / GenomeWeb Daily News